Cart summary

You have no items in your shopping cart.

Pritelivir

SKU: orb1223140

Description

Pritelivir (BAY 57-1293) is a potent helicase-primase inhibitor with active against HSV-1 and HSV-2 (IC50: 20 nM).(In Vivo):Pritelivir is the first in a class of antiviral agents that inhibit HSV replication by targeting the viral helicase-primase enzyme complex.Pritelivir (0.03-45 mg/kg) significantly increases survival. Pritelivir (0.3-30 mg/kg) reduces mortality against HSV-1, E-377. Pritelivir has potent and resistance-breaking antiviral efficacy with potential for the treatment of potentially life-threatening HSV type 1 and 2 infections, including herpes simplex encephalitis.Combination therapies of Pritelivir at 0.1 or 0.3 mg/kg/dose with Acyclovir (10 mg/kg/dose) are protective when compared to the vehicle treated group against HSV-2, strain MS.

Images & Validation

Key Properties

CAS Number348086-71-5
MW402.49
Purity>98% (HPLC)
FormulaC18H18N4O3S2
SMILESCc1c(sc(n1)N(C)C(=O)Cc1ccc(cc1)c1ccccn1)S(=O)(=O)N
TargetAntiviral
SolubilityDMSO : ≥ 33 mg/mL; 81.99 mM

Bioactivity

In Vivo
Pritelivir is the first in a class of antiviral agents that inhibit HSV replication by targeting the viral helicase-primase enzyme complex. Pritelivir (0.03-45 mg/kg) significantly increases survival. Pritelivir (0.3-30 mg/kg) reduces mortality against HSV-1, E-377. Pritelivir has potent and resistance-breaking antiviral efficacy with potential for the treatment of potentially life-threatening HSV type 1 and 2 infections, including herpes simplex encephalitis. Combination therapies of Pritelivir at 0.1 or 0.3 mg/kg/dose with Acyclovir (10 mg/kg/dose) are protective when compared to the vehicle treated group against HSV-2, strain MS. Animal model: Female BALB/c mice. Dosage: 0.03 to 45 mg/kg. Administration: Administered orally, twice daily at approximately 12 h intervals, for 7 days. Result: Survival was significantly increased to 80-100% as compared to the vehicle treatment. Even the lowest dose of 0.3 mg/kg was effective in increasing survival to 53%.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

BAY 57-1293 | AIC316

Similar Products

  • Pritelivir mesylate [orb783556]

    >98%

    1428333-96-3

    498.596180438995

    C19H22N4O6S3

    100 mg, 1 g, 250 mg
  • Pritelivir [orb2985779]

    >98%

    348086-71-5

    402.5

    C18H18N4O3S2

    50 mg, 10 mg
  • Pritelivir [orb1305384]

    99.42%

    348086-71-5

    402.49

    C18H18N4O3S2

    5 mg, 10 mg, 25 mg, 50 mg, 500 mg, 1 ml x 10 mM (in DMSO), 100 mg
  • Pritelivir mesylate hydrate [orb1706769]

    1428321-10-1

    516.61

    C19H24N4O7S3

    5 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Pritelivir (orb1223140)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 80.00
10 mg
$ 100.00
25 mg
$ 150.00
50 mg
$ 190.00
100 mg
$ 280.00
500 mg
$ 660.00